Kyverna Therapeutics Inc. (NASDAQ:KYTX) does about 625.35K shares in volume on a normal day but saw 1984843 shares change hands in the recent trading day. The company now has a market cap of 301.84M USD. Its current market price is $7.00, marking an increase of 7.20% compared to the previous close of $6.53. The 52 week high reached by this stock is $35.06 whilst the lowest price level in 52 weeks is $6.30.
Kyverna Therapeutics Inc. (KYTX) has a 20-day trading average at $8.38 and the current price is -80.03% off the 52-week high compared with 11.11% distance from its 52-week low. The 50-day simple moving average of the closing price is $9.27. If we look at the stock’s price movements over the week, volatility stands at 9.23%, which increases to 10.36% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 36.88 to suggest the stock is neutral.
The consensus objective for the share price is $41.25, suggesting that the stock has a potential upside of 83.03% over the period.
0 analysts have rated it as a buy and 1 have advised that investors hold their positions. The consensus recommendation rating is Hold and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on July 03, 2024 when H.C. Wainwright initiated the stock to “Neutral” and issued a price target of $8. Morgan Stanley initiated its price target at $40.
Kyverna Therapeutics Inc. (KYTX) stock is down -0.14% over the week and -29.36% over the past month. Its price is -76.67% year-to-date.
To reach the target analysts have set, the stock logically needs to grow 83.03 percent from here.
Price to book ratio is 0.91.
